IQ-AI Ltd. (IQAIF)
OTC PINK OTC PINK Primary Summary
IQAIF Chart
Imaging Biometrics to revise FDA application for brain cancer drug after positive feedback
Imaging Biometrics Ltd (LSE:IBAI, OTCQB:IQAIF), a specialist in imaging-based therapies for brain cancers, said it will revise its application for Breakthrough Therapy Designation in the US, following discussions with the Food and Drug Administration. The company is developing oral gallium maltolate, a treatment aimed at aggressive brain tumours that have not responded to standard therapies.
IQ-AI subsidiary applies to FDA for ‘breakthrough therapy'
IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) told investors that its wholly owned subsidiary, Imaging Biometrics, has submitted an application to the US Food and Drug Administration (FDA) for Breakthrough Therapy Designation. The application is for its oral gallium maltolate therapy, for treating adult patients with a certain kind of brain tumour (recurrent or refractory glioblastoma IDH-wildtype).
IQ-AI: Advancing AI for brain tumour care and clinical trials
IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) said it is making significant strides in using artificial intelligence (AI) to improve the diagnosis and treatment of brain tumours. Its subsidiary, Imaging Biometrics (IB), is at the forefront of developing AI-powered imaging solutions, with several updates set for 2025.
IQ-AI Ltd. Dividends
IQ-AI Ltd. Earnings
IQ-AI Ltd. (IQAIF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has IQ-AI Ltd. ever had a stock split?
IQ-AI Ltd. Profile
| Medical - Healthcare Information Services Industry | Healthcare Sector | Mr. Trevor Edward Brown M.B.A. CEO | OTC PINK Exchange | JE00BD4H0R42 ISIN |
| JE Country | 7 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
IQ-AI Limited is a company operating primarily in the healthcare sector, with subsidiaries developing advanced software applications. Headquartered in Saint Helier, Jersey, the company extends its services to the United Kingdom and the United States. Originating as Flying Brands Limited, it underwent a strategic rebranding to IQ-AI Limited in October 2018, reflecting its focus on intelligent solutions within the artificial intelligence domain for medical applications. Their offerings span a range of diagnostic and analytical tools, designed to integrate seamlessly with existing medical imaging systems and to support healthcare professionals by enhancing decision-making processes and patient care.
Products and Services
- IB Clinic: A comprehensive suite of post-processing software plugins designed for integration into existing medical image visualization applications. This toolkit enhances the capabilities of healthcare systems by providing advanced image analysis tools.
- IB Rad Tech: An innovative workflow engine developed to facilitate customized workflows. This technology is crafted to streamline operations within medical imaging, ensuring efficiency and flexibility in handling imaging processes.
- IB Neuro: Specialized software that processes MR data sets to generate parametric perfusion maps. These maps are crucial for quantifying changes in contrast over time, offering valuable insights into neurological conditions and aiding in diagnosing and monitoring treatments.
- IB Delta Suite: A versatile collection of tools that conduct fundamental radiology operations such as image co-registration, subtraction, class map generation, and export. This suite supports radiologists in delivering precise and accurate diagnostic information.
- IB DCE: Designed to work with conventional T1 weighted images, this product generates an array of perfusion and permeability parameters. It is an essential tool for understanding and assessing tissue perfusion and vascular permeability within the clinical setting.
- IB Diffusion: A sophisticated tool for analyzing MR diffusion-weighted images, generating maps that represent various parameters such as apparent diffusion coefficient, extrapolated b-value, IVIM, among others. These maps are critical for evaluating tissue structure integrity and are widely used in diagnosing and assessing numerous conditions.
- IB StoneChecker: A dedicated medical software tool that provides valuable information about a patient's kidney stones, aiding clinical decision making. It brings a data-driven approach to assessing stone composition and deciding on the most appropriate treatment strategy.
In addition to its product lineup, IQ-AI Limited also offers consulting services, leveraging its extensive expertise in medical imaging software to assist other organizations in navigating the complex landscape of healthcare technology.
Contact Information
